Related references
Note: Only part of the references are listed.CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients
Barbara Savoldo et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Multiple Injections of Electroporated Autologous T Cells Expressing a Chimeric Antigen Receptor Mediate Regression of Human Disseminated Tumor
Yangbing Zhao et al.
CANCER RESEARCH (2010)
Cytotoxicity of Activated Natural Killer Cells against Pediatric Solid Tumors
Duck Cho et al.
CLINICAL CANCER RESEARCH (2010)
IL-2-activated haploidentical NK cells restore NKG2D-mediated NK-cell cytotoxicity in neuroblastoma patients by scavenging of plasma MICA
Stephan Kloess et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
NKAML: A Pilot Study to Determine the Safety and Feasibility of Haploidentical Natural Killer Cell Transplantation in Childhood Acute Myeloid Leukemia
Jeffrey E. Rubnitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Mathematical Modeling of Chimeric TCR Triggering Predicts the Magnitude of Target Lysis and Its Impairment by TCR Downmodulation
Scott E. James et al.
JOURNAL OF IMMUNOLOGY (2010)
T Cells Engineered with a Cytomegalovirus-Specific Chimeric Immunoreceptor
Florian Full et al.
JOURNAL OF VIROLOGY (2010)
Adoptive cell therapy for the treatment of patients with metastatic melanoma
Steven A. Rosenberg et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
The promise and potential pitfalls of chimeric antigen receptors
Michel Sadelain et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
ULBP6/RAET1L is an additional human NKG2D ligand
Robert A. Eagle et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Transfer of mRNA encoding recombinant immunoreceptors reprograms CD4(+) and CD8(+) T cells for use in the adoptive immunotherapy of cancer
K. Birkholz et al.
GENE THERAPY (2009)
A high proportion of bone marrow T cells with regulatory phenotype (CD4+CD25hiFoxP3+) in Ewing sarcoma patients is associated with metastatic disease
Peter Brinkrolf et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo
Tadepally Lakshmikanth et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Endosomes: A legitimate platform for the signaling train
Jane E. Murphy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Chimeric NKG2D receptor-expressing T cells as an immunotherapy for multiple myeloma
Amorette Barber et al.
EXPERIMENTAL HEMATOLOGY (2008)
Activating NK cell receptor ligands are differentially expressed during progression to cervical cancer
Sonja Textor et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Antigen sensitivity of CD22-specific chimeric TCR is modulated by target epitope distance from the cell membrane
Scott T. James et al.
JOURNAL OF IMMUNOLOGY (2008)
NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways
Dirk H. J. Verhoeven et al.
MOLECULAR IMMUNOLOGY (2008)
NKG2D ligands in tumor immunity
N. Nausch et al.
ONCOGENE (2008)
Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi-modality therapy: A report from the Children's Oncology Group
Patrick J. Leavey et al.
PEDIATRIC BLOOD & CANCER (2008)
Treatment of metastatuc Ewing Sarcoma/Primitive neuroectodermal tumor of bone: Evaluation of increasing the dose intensity of chemotherapy - A report from the children's oncology group
James S. Miser et al.
PEDIATRIC BLOOD & CANCER (2007)
Analysis of prognostic factors in ewing sarcoma family of tumors -: Review of St. Jude Children's Rresearch Hospital studies
Carlos Rodriguez-Galindo et al.
CANCER (2007)
Chimeric NKG2D receptor-bearing T cells as immunotherapy for ovarian cancer
Arnorette Barber et al.
CANCER RESEARCH (2007)
Efficient chemokine-dependent migration and primary and secondary IL-12 secretion by human dendritic cells stimulated through toll-like receptors
Manfred Lehner et al.
JOURNAL OF IMMUNOTHERAPY (2007)
Expression of cellular FLICE inhibitory protein, caspase-8, and protease inhibitor-9 in Ewing sarcoma and implications for susceptibility to cytotoxic pathways
Alfons S. K. de Hooge et al.
CLINICAL CANCER RESEARCH (2007)
Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells
Silke Holtkamp et al.
BLOOD (2006)
Addition of the CD28 signaling domain to chimeric T-cell receptors enhances chimeric T-cell resistance to T regulatory cells
A. Loskog et al.
LEUKEMIA (2006)
Proteolytic release of soluble UL16-binding protein 2 from tumor cells
I Waldhauer et al.
CANCER RESEARCH (2006)
Release of MICB molecules by tumor cells: Mechanism and soluble MICB in sera of cancer patients
Helmut Rainer Salih et al.
HUMAN IMMUNOLOGY (2006)
Generation of antitumor responses by genetic modification of primary human T cells with a chimeric NKG2D receptor
Tong Zhang et al.
CANCER RESEARCH (2006)
Chimeric NK-receptor-bearing T cells mediate antitumor immunotherapy
T Zhang et al.
BLOOD (2005)
Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells
MR Verneris et al.
BLOOD (2004)
Cutting edge: Rapid in vivo killing by memory CD8 T cells
DL Barber et al.
JOURNAL OF IMMUNOLOGY (2003)
Symmetry recognizing asymmetry: Analysis of the interactions between the C-type lectin-like immunoreceptor NKG2D and MHC class I-like ligands
BJ McFarland et al.
STRUCTURE (2003)
Survival and tumor localization of adoptively transferred Melan-A-specific T cells in melanoma patients
N Meidenbauer et al.
JOURNAL OF IMMUNOLOGY (2003)
Signal transduction and endocytosis: Close encounters of many kinds
A Sorkin et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Contrasting IgG structures reveal extreme asymmetry and flexibility
EO Saphire et al.
JOURNAL OF MOLECULAR BIOLOGY (2002)
Cytokine production and cytolytic mechanism of CD4+ cytotoxic T lymphocytes in ex vivo expanded therapeutic Epstein-Barr virus-specific T-cell cultures
Q Sun et al.
BLOOD (2002)
Phase I trial of adoptive immunotherapy with cytolytic T lymphocytes immunized against a tyrosinase epitope
MS Mitchell et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Tumor-specific T cell activation by recombinant immunoreceptors:: CD3ζ signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can ge integrated into one combined CD28/CD3ζ signaling receptor molecule
A Hombach et al.
JOURNAL OF IMMUNOLOGY (2001)
Transfer of specificity for human immunodeficiency virus type 1 into primary human T lymphocytes by introduction of T-cell receptor genes
LJN Cooper et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
